Advertisement

Topics

Latest "PotNetwork Holding, Inc:" News Stories

16:25 EST 19th January 2019 | BioPortfolio

Here are the most relevant search results for "PotNetwork Holding, Inc:" found in our extensive news archives from over 250 global news sources.

More Information about PotNetwork Holding, Inc: on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PotNetwork Holding, Inc: for you to read. Along with our medical data and news we also list PotNetwork Holding, Inc: Clinical Trials, which are updated daily. BioPortfolio also has a large database of PotNetwork Holding, Inc: Companies for you to search.

Showing "PotNetwork Holding" News Articles 1–25 of 1,000+

Friday 18th January 2019

Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.


Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.

Thursday 17th January 2019

Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?

As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Ka...


QIAGEN N.V. to Report Fourth Quarter and Full Year 2018 Results

QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as previously announced to release its report on results for the fourth quarter 2018 on Monday, February 4 at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EST). A conference call is planned for Tuesday, February 5 at 15:00 CET / 9:00 EST hosted by Peer M. Schatz...

Roche's uPath digital pathology software launched

Roche Holding has announced the launch of uPath, touted as an upgrade to its Ventana Virtuoso image-management software.  -More- 

Roche's sBLA for Tecentriq plus chemo accepted for FDA review

Roche Holding's supplemental biologics license application for Tecentriq plus chemotherapy (abraxane and carboplatin) as a fi -More- 

Roche signs triple-negative breast cancer biomarker deal with Phoenix

Roche Holding agreed to collaborate with Phoenix Molecular Designs to develop an assay that will detect activation of RPS6KA3 -More- 

Wednesday 16th January 2019

OKI and ARC Innovation Center at Sheba Join Forces to Prevent Dementia

Overview of "Very Accurate Health Score"Jerusalem, Jan 16, 2019 - (JCN Newswire) - OKI and ARC Innovation Center at Sheba (Sheba), the largest medical facility in the Middle East, have agreed to pursue research on the prevention of dementia, aiming at a society in which the elderly can remain active according to their health with a 'Very Accurate Health Score' (*1) from the re...

OneLegacy Announces Record-Setting Year in Organ, Eye and Tissue Donation and Transplantation

More Than 1,500 Lifesaving Organs, 150,000 Tissues and Nearly 1,300 Corneas Transplanted in 2018 as More People Embrace the Power of Donation OneLegacy, the Los Angeles-based nonprofit organ procurement organization dedicated to saving and healing lives through organ, eye and tissue donation, announced today a record number of organ donors in...

Conception Nurseries, a Leading Cannabis Micropropagation Company, Comes out of Quiet Production and Launches Publicly Today

Conception Nurseries, a cannabis micropropagation company that has been quietly developing cannabis tissue culture clones for nearly two years, is now launching publicly. Conception is bringing tissue culture technology, a crucial component of industrial scale agriculture, to the cannabis industry. With tissue culture micropropagation, Conception produces ...

Tuesday 15th January 2019

10 Career-Killing Habits to Drop in 2019

The New Year is an excellent time to re-evaluate the state of your professional life and take honest stock of your accomplishments and strengths, as well as the shortcomings or bad habits that may be holding you back from achieving the career or success that you want.

New Book by Dale Brown Offers Hope and Practical Advice to Divorced Men: "Daily Survival Guide for Divorced Men: Surviving & Thriving Beyond Your Divorce Days 1-91"

Over 15,000 divorces are filed every week yet the grief and loss among this enormous segment of our population goes unnoticed. The consequences can be deadly. Divorced men are more likely to engage in risky, addictive behavior and commit suicide or homicide. Yet few resources exist to guide a man through the minefield of divorce. "Daily Survival Guide for Divorce Men" fills this gap. AU...

Monday 14th January 2019

Identifying Demand Management Best Practices to Track the Performance of Medical Devices – A Report by Infiniti Research

A well-known market intelligence company, Infiniti Research, has announced the completion of their latest article on the demand management best practices for medical devices’ performance tracking. This press release features multimedia. View the full release here:

How a 'regulatory dead zone' may be holding up copycat insulin

The FDA has talked up biosimilars' potential impact on the insulin market, but changing regulations have complicated matters for would-be competitors.

How the FDA may be holding up insulin copies

FDA head Scott Gottlieb has talked up the idea of biosimilars coming to the insulin market, but changing regulations have complicated matters for would-be competitors.

Ferring Pharmaceuticals adds two products to its robust reproductive health portfolio in the U.S.

Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women undergoing fertility treatment Deal complete with INVO Bioscience Inc. for exclusive U.S. commercialization rights for the INVOcell™ Intravaginal Culture System ...

Generex signs LOI to buy Medisource Partners

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis via delivery of personalized therapies. Medisource distributes bone grafts and The post Generex signs LOI to buy Medisource Partners appeared first on Compelo Medical Devices.

Friday 11th January 2019

Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries

NEW YORK, January 11, 2019 /PRNewswire/ -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the "Company," or AMBS), a US-based JLABS-alumnus biotechnology holding company developing first-in...

aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

aap Implantate AG 11.01.2019 / 09:48 Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: aap Implantate AG Street: Lorenzweg 5 Postal code: 12099 City: BerlinGermany Legal Entity Identifier (LEI...

Thursday 10th January 2019

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018

Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (January 10, 2019 - 6:00 pm) As of December 31, 2018, shares and voting rights outstanding of EssilorLuxottica, t...

Generex Biotechnology Announces Investor Conference Call; Management to Provide Update on Acquisitions, Financing Initiatives & Strategic Plans

Acquisition review on NuGenerex family of subsidiary companies Spin-out of NuGenerex Immuno-Oncology as a standalone public company Plans for up-list of Generex Biotechnology Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Wed...

RHÖN-KLINIKUM AG RHÖN-KLINIKUM AG enters into the new world of telemedicine in Germany together with Medgate - Memorandum of understanding to establish joint company with telemedicine provider Medgate

DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Letter of Intent/Miscellaneous 10.01.2019 / 09:52 The issuer is solely responsible for the content of this announcement. Corporate News Bad Neustadt / Saale | 10th January 2019 RHÖN-KLINIKUM AG enters into the new world of telemedicine in Germany together with Medgate - Memorandum of understanding to establish joint company with telemedicin...

RHÖN-KLINIKUM AG signs memorandum of understanding regarding establishment of joint company with Swiss telemedicine provider Medgate

RHÖN-KLINIKUM AG / Key word(s): Letter of Intent RHÖN-KLINIKUM AG signs memorandum of understanding regarding establishment of joint company with Swiss telemedicine provider Medgate 10-Jan-2019 / 09:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible f...

Wednesday 9th January 2019

Five New Year’s Resolutions for Professional Success in 2019

A new year calls for a renewed sense of focus, direction, and motivation in your career. It’s a time to let go of the bad habits that have been holding you back professionally, and replace them with newer, better strategies that will help you to have a year of growth and success in 2019.

MedMen Enterprises Releases Response to ‘Shareholder Lawsuit’

On January 8th, two early investors in MMMG, LLC, a precursor company to MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) (FSE: A2JM6N) filed a complaint in Los Angeles Superior Court alleging unfair treatment regarding the disposition of their investment in MMMG. Today, a Los Angeles Superior Court den...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks